Quince Therapeutics Inc. (QNCX)

1.46

0.01 (0.69%)

At close: Mar 03, 2025, 3:59 PM

1.43

-1.99%

After-hours: Mar 03, 2025, 06:13 PM EST

Quince Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-31.39M	-51.66M	-89.94M	-76.85M	-36.98M	-12.48M	-12.23M
Depreciation & Amortization	322K	204K	344K	332K	188K	51K	45K
Stock-Based Compensation	5.22M	16.62M	29.85M	14.47M	2.06M	155K	38K
Other Working Capital	2.27M	-3.89M	-5.62M	9.75M	-676K	-367K	237K
Other Non-Cash Items	5.82M	913K	199K	367K	367K	1.11M	1.64M
Deferred Income Tax	-248K	-284K	878K	635K	-812K	-145K	222K
Change in Working Capital	1.98M	-9.83M	-4.26M	10.23M	1.9M	-390K	460K
Operating Cash Flow	-18.29M	-44.04M	-62.93M	-50.82M	-33.28M	-11.7M	-9.83M
Capital Expenditures	-160K	-133K	-180K	-52K	-55K	-212K	-77K
Acquisitions	-2.12M	10.59M	-58.95M	52.43M	-812K	n/a	n/a
Purchase of Investments	-113.78M	-75.02M	-38.79M	-187.14M	-135.41M	-55.24M	n/a
Sales Maturities Of Investments	111.21M	82.49M	97.92M	134.76M	117.72M	8.7M	n/a
Other Investing Acitivies	-910K	70K	58.95M	-52.43M	812K	-46.54M	n/a
Investing Cash Flow	-5.76M	18M	58.95M	-52.43M	-17.75M	-46.75M	-77K
Debt Repayment	-6K	-49K	n/a	-34K	-559K	250K	7.75M
Common Stock Repurchased	63.73M	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	149K	148K	6.81M	1.28M	98K	75.68M	n/a
Financial Cash Flow	143K	707K	6.81M	118.88M	77.37M	75.93M	7.75M
Net Cash Flow	-23.83M	-25.14M	2.88M	15.63M	26.34M	17.48M	-2.15M
Free Cash Flow	-18.45M	-44.17M	-63.11M	-50.87M	-33.33M	-11.91M	-9.9M